Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: A randomized double-blind placebo-controlled clinical trial (the PROTECT trial)

Vox Sanguinis

Volumn 109, Issue 3, 2015, Pages 257-266

  Johansson, P I ^a   Rasmussen, A S ^a   Thomsen, Lars L ^b  

^a Rigshospitalet   (Denmark)

^b Pharmacosmos AS   (Denmark)

Author keywords

Anaemia; Coronary artery bypass surgery; Iron

Indexed keywords

IRON DERIVATIVE; IRON ISOMALTOSIDE 1000; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG; DISACCHARIDE; FERRIC ION; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; BLOOD TRANSFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; HAND DISEASE; HEART VALVE REPLACEMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOPHOSPHATEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE ANEMIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; THRUSH; CLINICAL TRIAL; CORONARY DISEASE; ELECTIVE SURGERY; MIDDLE AGED; PLACEBO EFFECT; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISACCHARIDES; DOUBLE-BLIND METHOD; ELECTIVE SURGICAL PROCEDURES; FEMALE; FERRIC COMPOUNDS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84941598898     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12278     Document Type: Article

References (17)

1. WHO: Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, World Health Organization, 2011. http://www.who.int/mediacentre/factsheets/fs317/en/
2. Nalysnyk L, Fahrbach K, Reynolds MW, et al.: Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 2003; 89:767-772
3. Munoz M, Gomez-Ramirez S, Martin-Montanez E, et al.: Perioperative intravenous iron: an upfront therapy for treating anaemia and reducing transfusion requirements. Nutr Hosp 2012; 27:1817-1836
4. Beris P, Munoz M, Garcia-Erce JA, et al.: Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100:599-604
5. Koch CG, Li L, Duncan AI, et al.: Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81:1650-1657
6. Murphy GJ, Reeves BC, Rogers CA, et al.: Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-2552
7. Surgenor SD, Kramer RS, Olmstead EM, et al.: The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108:1741-1746
8. George TJ, Beaty CA, Kilic A, et al.: Hemoglobin drift after cardiac surgery. Ann Thorac Surg 2012; 94:703-709
9. Lachance K, Savoie M, Bernard M, et al.: Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011; 45:764-770
10. Leal-Noval SR, Munoz M, Paramo JA, et al.: Spanish consensus statement on alternatives to allogeneic transfusions: the "Seville document". TATM 2006; 8:178-202
11. Lidder PG, Sanders G, Whitehead E, et al.: Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial. Ann R Coll Surg Engl 2007; 89:418-421
12. Leal-Noval SR, Munoz M, Asuero M, et al.: Spanish consensus statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus 2013; 11:585-610
13. Garrido-Martín P, Nassar-Mansur MI, de la Llana-Ducrós R, et al.: The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg 2012; 15:1013-1018
14. Andrews CM, Lane DW, Bradley JG: Iron pre-load for major joint replacement. Transfus Med 1997; 7:281-286
15. Bisbe E, Garcia-Erce JA, Diez-Lobo AI, et al.: A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107:477-478
16. Garcia-Erce JA, Cuenca J, Martinez F, et al.: Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006; 16:335-341
17. Kalra PA, Bock K, Meldal M: Iron isomaltoside 1000: a new high dose option for parenteral iron therapy. Port J Nephrol Hypert 2012; 26:13-24